Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 323, doi. 10.1007/s40256-015-0124-5
- By:
- Publication type:
- Article
Works matching IS 11753277 AND DT 2015 AND VI 15 AND IP 5
Results: 9
1
2
Pharmacotherapeutic Considerations for Using Colchicine to Treat Idiopathic Pericarditis in the USA.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 295, doi. 10.1007/s40256-015-0133-4
- By:
- Publication type:
- Article
3
Time to Reconsider Dabigatran 110 mg in the USA.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 307, doi. 10.1007/s40256-015-0137-0
- By:
- Publication type:
- Article
4
Comment on: 'Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag'.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 371, doi. 10.1007/s40256-015-0142-3
- By:
- Publication type:
- Article
5
Authors' Reply to Srinivas: 'Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag'.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 373, doi. 10.1007/s40256-015-0143-2
- By:
- Publication type:
- Article
6
Perindopril/Amlodipine (Prestalia): A Review in Hypertension.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 363, doi. 10.1007/s40256-015-0144-1
- By:
- Publication type:
- Article
7
One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 337, doi. 10.1007/s40256-015-0147-y
- By:
- Publication type:
- Article
8
Edoxaban: A Review in Nonvalvular Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 351, doi. 10.1007/s40256-015-0148-x
- By:
- Publication type:
- Article
9
Risks and Benefits of Low Molecular-Weight Heparin and Target-Specific Oral Anticoagulant Use for Thromboprophylaxis in Medically Ill Patients.
- Published in:
- American Journal of Cardiovascular Drugs, 2015, v. 15, n. 5, p. 311, doi. 10.1007/s40256-015-0122-7
- By:
- Publication type:
- Article